Delusions and hallucinations in Alzheimer's disease: review of the brain decade.

The authors reviewed studies published from 1990 to 2001 that address the epidemiology, phenomenology, course, etiology, assessment, and treatment of delusions and hallucinations in Alzheimer's disease. The prevalence of delusions in Alzheimer's disease patients ranged from 16% to 70% (median=36.5%) in the reviewed reports, and the prevalence of hallucinations ranged from 4% to 76% (median=23%). Delusions and hallucinations tended to persist over time, tended to recur often during the course of Alzheimer's disease, and were associated with sociodemographic and clinical correlates that differed from one study to another and with substantial consequences such as functional impairment and aggression. Psychosocial methods and both typical and atypical antipsychotics are effective in the treatment of delusions and hallucinations in Alzheimer's disease.

[1]  G. Zubenko,et al.  Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease , 1991, Biological Psychiatry.

[2]  P. Scheltens,et al.  White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging , 1999, Journal of neurology, neurosurgery, and psychiatry.

[3]  M. Albert,et al.  Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease , 1994, Neurology.

[4]  T. Powell,et al.  A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[5]  N. Gormley,et al.  Prevalence and clinical correlates of psychotic symptoms in Alzheimer's disease , 1998, International journal of geriatric psychiatry.

[6]  Mental and Behavioral Disturbances in Dementia: Findings from the Cache County Study on Memory in Aging , 2000 .

[7]  R. Doody,et al.  Positive and negative neuropsychiatric features in Alzheimer's disease. , 1995, The Journal of neuropsychiatry and clinical neurosciences.

[8]  P. Rabins,et al.  Risk factors for developing atypical (schizophreniform) psychosis following stroke. , 1991, The Journal of neuropsychiatry and clinical neurosciences.

[9]  J. Cummings,et al.  Noncognitive neuropsychiatric syndromes in alzheimer’s disease , 1990 .

[10]  A. Burns,et al.  Psychiatric Phenomena in Alzheimer's Disease. I: Disorders of Thought Content , 1990, British Journal of Psychiatry.

[11]  K. Marder,et al.  A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease , 1996, Neurology.

[12]  W W Offen,et al.  The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease. , 1997, Alzheimer disease and associated disorders.

[13]  R. Leiguarda,et al.  Neuropsychiatric and neuropsychological correlates of delusions in Alzheimer's disease , 1995, Psychological Medicine.

[14]  G. Ramaswamy,et al.  A new scale for assessing behavioral agitation in dementia , 1992, Psychiatry Research.

[15]  M. Esiri,et al.  Psychosis of Alzheimer’s disease is associated with elevated muscarinic M2 binding in the cortex , 2001, Neurology.

[16]  K. Ishii,et al.  Alteration of regional cerebral glucose utilization with delusions in Alzheimer's disease. , 1998, The Journal of neuropsychiatry and clinical neurosciences.

[17]  R. Schiffer,et al.  Psychiatric features in diffuse Lewy body disease , 1996, Neurology.

[18]  G. Grossberg,et al.  The Evolution of Psychiatric Symptoms in Alzheimer's Disease: A Natural History Study , 1996, Journal of the American Geriatrics Society.

[19]  A W Toga,et al.  Cerebral correlates of psychotic symptoms in Alzheimer's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.

[20]  J. Cummings,et al.  Quantitative electroencephalographic correlates of psychosis in Alzheimer disease. , 2000, Neuropsychiatry, neuropsychology, and behavioral neurology.

[21]  S. Wisniewski,et al.  Psychotic Symptoms in Alzheimer's Disease Are Not Associated With More Severe Neuropathologic Features , 2000, International Psychogeriatrics.

[22]  G. Small,et al.  Apolipoprotein E genotype and noncognitive symptoms in Alzheimer’s disease , 1999, Biological Psychiatry.

[23]  J. Becker,et al.  Alzheimer's disease with delusions and hallucinations , 1991, Neurology.

[24]  D. Jeste,et al.  A Study of Delusions in a Large Cohort of Alzheimer's Disease Patients. , 1994, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[25]  J. Becker,et al.  The psychotic phenomenon in probable Alzheimer's disease: a positron emission tomography study. , 2001, The Journal of neuropsychiatry and clinical neurosciences.

[26]  D. G. Gorman,et al.  Physostigmine ameliorates the delusions of Alzheimer's disease , 1993, Biological Psychiatry.

[27]  G. Vega,et al.  Apolipoprotein eϵ4, other risk factors, and course of alzheimer’s disease , 1999, Biological Psychiatry.

[28]  Hans Förstl,et al.  [Incidence and importance of "non-cognitive" symptoms in dementia of the Alzheimer type: productive psychotic symptoms, depressive disorders and behavioral disorders]. , 1993, Zeitschrift fur Gerontologie.

[29]  K. Marder,et al.  The Columbia University Scale for Psychopathology in Alzheimer's disease. , 1992, Archives of neurology.

[30]  J. Cummings,et al.  Assessment of Cognitive, Psychiatric, and Behavioral Disturbances in Patients with Dementia: The Neurobehavioral Rating Scale , 1992, Journal of the American Geriatrics Society.

[31]  J. Moossy,et al.  Neuropathologic and neurochemical correlates of psychosis in primary dementia. , 1991, Archives of neurology.

[32]  H. Sackeim,et al.  Behavioral Syndromes in Alzheimer's Disease , 1992, International Psychogeriatrics.

[33]  F. Bymaster,et al.  Elucidating the role of muscarinic receptors in psychosis. , 2001, Life sciences.

[34]  Wayne C. Drevets,et al.  Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type , 1989, Biological Psychiatry.

[35]  H. Sackeim,et al.  A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. , 1998, The American journal of psychiatry.

[36]  A. Kurz,et al.  DELUSIONS AND HALLUCINATIONS IN ALZHEIMER'S DISEASE: RESULTS FROM A TWO‐YEAR LONGITUDINAL STUDY , 1996 .

[37]  R. Young,et al.  AGE AND PSYCHOSIS IN DEGENERATIVE DEMENTIA , 1997, International journal of geriatric psychiatry.

[38]  S. Lovestone,et al.  Clinical predictors of aggressive behaviour in Alzheimer's disease , 1998, International journal of geriatric psychiatry.

[39]  Robert P. Friedland,et al.  Dementia: A Clinical Approach (2nd Ed.) , 1992 .

[40]  L. Schneider,et al.  A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia , 1990, Journal of the American Geriatrics Society.

[41]  Jeffrey L. Cummings,et al.  The spectrum of behavioral changes in Alzheimer's disease , 1996, Neurology.

[42]  B. Gulanski,et al.  Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease , 1998, Neurology.

[43]  D. Benson,et al.  Dementia: A Clinical Approach , 1983 .

[44]  P J Whitehouse,et al.  Psychiatric symptoms associated with Alzheimer's disease. , 1990, The Journal of neuropsychiatry and clinical neurosciences.

[45]  J. Cummings,et al.  The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease. , 1995, The Journal of neuropsychiatry and clinical neurosciences.

[46]  D. Collier,et al.  Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation , 2001, Journal of neurology, neurosurgery, and psychiatry.

[47]  J. Cummings,et al.  Cholinesterase inhibitors: A new class of psychotropic compounds. , 2000, The American journal of psychiatry.

[48]  R. Mayeux,et al.  Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. , 1991, Archives of neurology.

[49]  D. Jeste,et al.  Cognitive deficits of patients with Alzheimer's disease with and without delusions. , 1992, The American journal of psychiatry.

[50]  D. Jeste,et al.  Overview of depression and psychosis in Alzheimer's disease. , 1989, The American journal of psychiatry.

[51]  Hans Förstl,et al.  Psychotic features and the course of Alzheimer's disease: relationship to cognitive, electroencephalographic and computerized tomography findings , 1993, Acta psychiatrica Scandinavica.

[52]  J. Cummings,et al.  Depressive Symptoms in Alzheimer Disease: Assessment and Determinants , 1995, Alzheimer disease and associated disorders.

[53]  S H Ferris,et al.  Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. , 1987, The Journal of clinical psychiatry.

[54]  J. Miller,et al.  Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis. , 2000, Archives of general psychiatry.

[55]  Jiska Cohen-Mansfield,et al.  Nonpharmacologic Interventions for Inappropriate Behaviors in Dementia: A Review, Summary, and Critique , 2001 .

[56]  Jane S. Paulsen,et al.  Incidence of and risk factors for hallucinations and delusions in patients with probable AD , 2000, Neurology.

[57]  D. Jeste,et al.  Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. , 1999, The Journal of clinical psychiatry.

[58]  M. Haupt,et al.  Presentation and stability of noncognitive symptom patterns in patients with Alzheimer disease. , 1998, Alzheimer disease and associated disorders.

[59]  H. Spinnler,et al.  Variables linked to psychotic symptoms in Alzheimer's disease , 1998, European journal of neurology.

[60]  C. Sadowsky,et al.  Effect of tacrine on language, praxis, and noncognitive behavioral problems in Alzheimer disease. , 1997, Archives of neurology.

[61]  M F Weiner,et al.  The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. , 1995, The American journal of psychiatry.

[62]  M. Folstein,et al.  Psychosis and physical aggression in probable Alzheimer's disease. , 1991, The American journal of psychiatry.

[63]  G. Frisoni,et al.  Temporal lobe asymmetry in patients with Alzheimer's disease with delusions , 2000, Journal of neurology, neurosurgery, and psychiatry.

[64]  P. S. St George-Hyslop,et al.  Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease. , 1999, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[65]  J. Cummings,et al.  Neuropsychiatric Symptoms and Cholinergic Therapy for Alzheimer’s Disease , 1999, Gerontology.

[66]  J. Becker,et al.  The apolipoprotein E ϵ4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease , 1997, Neurology.

[67]  C. Lyketsos,et al.  The relationship between delusions and depression in Alzheimer's disease , 2002, International journal of geriatric psychiatry.

[68]  B. Lawlor,et al.  A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia , 1999, Neurology.

[69]  G. Lenzi,et al.  Delusions and dementia: clinical and CT correlates , 1995, Acta neurologica Scandinavica.

[70]  A. Kurz,et al.  Predictors of nursing home placement in patients with alzheimer's disease , 1993 .

[71]  C. Ballard,et al.  Associations of Psychotic Symptoms in Dementia Sufferers , 1995, British Journal of Psychiatry.

[72]  D. Drachman,et al.  The Caretaker Obstreperous‐Behavior Rating Assessment (COBRA) Scale , 1992, Journal of the American Geriatrics Society.

[73]  C. Lyketsos,et al.  Isolated hallucinosis in Alzheimer's disease is associated with African–American race , 2002, International journal of geriatric psychiatry.

[74]  S. Gauthier,et al.  Validity and Reliability of the Dementia Behavior Disturbance Scale , 1990, Journal of the American Geriatrics Society.

[75]  D. Jeste,et al.  Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. , 2000, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[76]  C. Lyketsos,et al.  Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study , 2001, International journal of geriatric psychiatry.

[77]  A. Kurz,et al.  A 2-Year Follow-Up of Behavioural and Psychological Symptoms in Alzheimer’s Disease , 2000, Dementia and Geriatric Cognitive Disorders.

[78]  T. Shimomura,et al.  Factors associated with psychotic symptoms in Alzheimer’s disease , 1998, Journal of neurology, neurosurgery, and psychiatry.

[79]  C. Lyketsos,et al.  Relationship of cognitive and functional impairment to depressive features in Alzheimer's disease and other dementias. , 1998, The Journal of neuropsychiatry and clinical neurosciences.

[80]  R. Tamura,et al.  Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. , 2000, Archives of general psychiatry.

[81]  T Hope,et al.  The Present Behavioural Examination (PBE): the development of an interview to measure current behavioural abnormalities , 1992, Psychological Medicine.

[82]  Philip D. Harvey,et al.  Noncognitive Disturbances in Alzheimer's Disease: Frequency, Longitudinal Course, and Relationship to Cognitive Symptoms , 1997, Journal of the American Geriatrics Society.

[83]  M. Albert,et al.  The course of psychopathologic features in mild to moderate Alzheimer disease. , 1997, Archives of general psychiatry.

[84]  B. Miller,et al.  Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer's disease. , 1996, The American journal of psychiatry.

[85]  J. Cohen-Mansfield,et al.  Delusions and hallucinations in an adult day care population. A longitudinal study. , 1998, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[86]  T. Hope,et al.  Manchester and Oxford Universities Scale for the Psychopathological Assessment of Dementia (MOUSEPAD) , 1996, British Journal of Psychiatry.

[87]  G. Peavy,et al.  An instrumental study of the relationship between extrapyramidal signs and psychosis in Alzheimer's disease. , 2000, The Journal of neuropsychiatry and clinical neurosciences.

[88]  R. Leiguarda,et al.  Prevalence and correlates of aggressive behavior in Alzheimer's disease. , 1998, The Journal of neuropsychiatry and clinical neurosciences.

[89]  D. Leo,et al.  Delusions in Alzheimer's disease and multi‐infarct dementia , 1993, Acta neurologica Scandinavica.

[90]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[91]  J. Morris,et al.  Psychopathology in younger versus older persons with very mild and mild dementia of the Alzheimer type. , 1993, The American journal of psychiatry.

[92]  D. Devanand The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer disease. , 1999, Alzheimer disease and associated disorders.

[93]  C. Lyketsos,et al.  Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates , 2000, International journal of geriatric psychiatry.

[94]  J. Cummings Psychosis in neurologic disease : neurobiology and pathogenesis : Psychosis in neurologic diseases , 1992 .

[95]  R. Ownby,et al.  Concomitants of visual hallucinations in Alzheimer's disease , 1994, Neurology.

[96]  Alistair Burns Assessment scales in old age psychiatry , 1999 .

[97]  C. Lyketsos,et al.  An evidence‐based proposal for the classification of neuropsychiatric disturbance in Alzheimer's disease , 2001, International journal of geriatric psychiatry.

[98]  Acute agitation and other behaviors associated with Wernicke aphasia and their possible neurological bases , 1993 .

[99]  O. Lopez,et al.  Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease. , 1998, Archives of neurology.

[100]  C. Lyketsos,et al.  Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[101]  R. Levy,et al.  Neuropathological Correlates of Psychotic Phenomena in Confirmed Alzheimer's Disease , 1994, British Journal of Psychiatry.

[102]  P. Haddad,et al.  Visual Hallucinations as the Presenting Symptom of Senile Dementia , 1992, British Journal of Psychiatry.

[103]  Richard J Martin,et al.  Assessment of Behavioral and Affective Symptoms in Alzheimer's Disease , 1990, Journal of geriatric psychiatry and neurology.

[104]  D. Bennett,et al.  Hallucinations and associated factors in Alzheimer's disease. , 1991, The Journal of neuropsychiatry and clinical neurosciences.

[105]  E. Rubin Delusions as part of Alzheimer's disease : Psychosis in neurologic diseases , 1992 .

[106]  P. Tariot,et al.  Long-Term use of quetiapine in elderly patients with psychotic disorders. , 2000, Clinical therapeutics.

[107]  S. Wisniewski,et al.  Alterations of striatal dopamine receptor binding in Alzheimer disease are associated with Lewy body pathology and antemortem psychosis. , 2001, Archives of neurology.

[108]  L A Beckett,et al.  Hallucinations, delusions, and cognitive decline in Alzheimer's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.

[109]  Constantine G. Lyketsos,et al.  Practical Dementia Care , 1999 .

[110]  K. Kotrla,et al.  Clinical variables associated with psychosis in Alzheimer's disease. , 1995, The American journal of psychiatry.

[111]  J. Cummings,et al.  Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. , 1996, The American journal of psychiatry.

[112]  J. Cummings,et al.  Delusions in dementia syndromes: investigation of behavioral and neuropsychological correlates. , 1991, The Journal of neuropsychiatry and clinical neurosciences.

[113]  K. Lapane,et al.  Gender differences in the treatment of behavior problems in Alzheimer’s disease , 2000, Neurology.